Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Regenerative Medicine
Filter     Order     Display # 
Date Item Title
22 Aug 2008 Mesoblast's allogenic, "off the shelf", stem cells are safe and effective for cervical spine fusion
12 Aug 2008 Kuros Biosurgery AG Announces Results Of ONE-Month Follow-Up Of Phase IIa Trial of KUR-212 in Patients with Burns requiring Mesh Grafting; KUR-212 Meets Phase IIa Trial Primary Endpoint
29 Jul 2008 Nuvelo Initiates Phase 1 Clinical Trial of NU206 in Healthy Volunteers
19 May 2008 Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder with Tengion Neo-Bladder Replacement(TM)
17 Apr 2008 12 Month Analysis of Juvista Clinical Trials 0050 and 0036
29 Mar 2008 OrthoLogic Announces Initiation of Dosing for AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring
21 Mar 2008 Mentor Corporation Announces FDA Approval of Prevelle Silk: First Dermal Filler to Prove Pain Reduction in the U.S.
17 Mar 2008 BioSyntech Announces Positive Preliminary Interim Data for BST-CarGel(R) Clinical Trial
13 Mar 2008 Glycotex Completes Enrollment in Phase IIa Study of Lead Product Candidate GLYC-101 for Wound Healing
13 Mar 2008 Nitric BioTherapeutics Launches Phase II Clinical Trial for the Use of Nitric Oxide in the Healing of Chronic Wounds
03 Mar 2008 Juvista Phase II Trial Results in Scar Revision and Breast Augmentation Surgery
06 Feb 2008 Tornier And BioSET Enter Synthetic Growth Factor Pact
24 Jan 2008 Derma Sciences to Enter Phase II Development of Wound Healing Product that May Use Body's Own Naturally Occurring Stem Cells
16 Jan 2008 Pfizer and Scil Finalize Agreement for Novel Cartilage Growth Factor
07 Jan 2008 Glycotex, Inc. Obtains Active IND From US Food and Drug Administration for GLYC-101 Wound Healing Compound
03 Jan 2008 Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
28 Dec 2007 Curis, Inc. Announces Sale of its BMP-7 Assets to Stryker Corporation
18 Dec 2007 Year-end clinical trial update
18 Dec 2007 Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx® GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
13 Dec 2007 BioMimetic Therapeutics Reports Positive Clinical Results for GEM OS(R)1 in Canadian Foot and Ankle Fusion Study; Clinical Success Rate of 90% Achieved in a High Risk Patient Population
07 Dec 2007 Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the OARSI 2007 World Congress on Osteoarthritis
14 Nov 2007 Cardium Initiates Phase 2b Excellarate Clinical Study for Diabetic Ulcers
13 Nov 2007 Genzyme Receives FDA Response Letter on Synvisc-One (TM)
19 Oct 2007 Aastrom Stem Cell Therapy Demonstrates Positive Results in Severe Long Bone Non-Union Fracture Trial
11 Oct 2007 Advitech Announces Positive Preclinical Results for Wound-Healing Application
03 Oct 2007 CardioVascular BioTherapeutics Completes Phase I Wound Healing Trial
28 Sep 2007 Nuvelo Announces Publication of NU206 Study Results in Proceedings of the National Academy of Sciences of the United States of America
17 Jul 2007 Findings from Four Year, Multi-Center Clinical Study on Autologous Chondrocyte Implantation Presented, Coincide with New Product Labeling
14 Jul 2007 BioMimetic Therapeutics' Clinical Investigator Presents Positive Interim Data on U.S. and Canadian Foot and Ankle Clinical Trials
04 Jul 2007 Mentor Announces Initial Patient Injections in Phase III Study for PurTox(R) Botulinum Toxin Type A
26 Jun 2007 Genzyme Receives FDA Approval for New Labeling for Carticel(R)
15 Jun 2007 BioSyntech reaches significant BST-CarGel(R) clinical milestone
14 Jun 2007 Lifecell Corporation receives 510(k) clearance for tissue repair product
12 Jun 2007 Biotec Pharmacon enters Phase III with the diabetic ulcers indication
08 Jun 2007 BioMimetic Therapeutics Initiates Enrollment in E.U. Registration Trial for GEM OS(R)1 Bone Graft; U.S. GEM OS1 Pivotal Study Protocol Amended to Allow Shorter Follow-Up Time and More Patients
23 May 2007 Scil Technology GmbH obtained Competent Authority Approval for Phase II Periodontitis Study
22 May 2007 Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
22 May 2007 Oculus Initiates Patient Enrollment in Phase II Study of Microcyn(R) Technology for Treatment of Mild Diabetic Foot Infections
02 May 2007 KCI Announces Positive Results From Clinical Study Utilizing V.A.C.(R) Therapy in the Treatment of Diabetic Foot Ulcers
18 Apr 2007 Prevascar Phase II Results
22 Feb 2007 BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteonecrosis of the Jaw
22 Feb 2007 Orthovita Announces Completion of Patient Enrollment in Its U.S. Pivotal Clinical Study for the Use of CORTOSS(R) in the Treatment of Vertebral Compression Fractures
17 Feb 2007 OrthoLogic Announces Results of Post Hoc Subgroup Analysis of Data From Phase 3 Clinical Trial of Chrysalin (TP508) in Fracture Repair
16 Feb 2007 Stem Cell Sciences and Celogos Sign a Licensing Deal on Autogenous Myoblast Transplantation For Urinary Incontinence Therapy
15 Feb 2007 Aastrom's U.S. Clinical Investigator to Report Interim Data on Long Bone Fracture Repair Trial
14 Feb 2007 Osiris Announces Top-Line Interim Results for Stem Cell Trial for Knee Repair
09 Feb 2007 Advanced BioHealing Enrolls First Patient in Celaderm Pilot Venous Leg Ulcer Clinical Trial
09 Feb 2007 BioSyntech announces start of patient recruitment into BST-DermOn(TM) pivotal clinical trial
26 Jan 2007 BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS®1 to Treat Distal Radius Fractures
25 Jan 2007 Scil Technology Completes Patient Enrollment in European Phase II Sinus Lift Study
 
<< Start < Prev 1 2 3 Next > End >>
Results 1 - 50 of 148

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Toll-Like Receptor (TLR) Agonists & Antagonists

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics